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Abstract
Previous studies have linked aspartame consumption to impaired retention of learned behavior in rodents. Prenatal
exposure to aspartame has also been shown to impair odor-associative learning in guinea pigs; and recently, aspartame-fed
hyperlipidemic zebrafish exhibited weight gain, hyperglycemia and acute swimming defects. We therefore investigated the
effects of chronic lifetime exposure to aspartame, commencing in utero, on changes in blood glucose parameters, spatial
learning and memory in C57BL/6J mice. Morris Water Maze (MWM) testing was used to assess learning and memory, and a
random-fed insulin tolerance test was performed to assess glucose homeostasis. Pearson correlation analysis was used to
investigate the associations between body characteristics and MWM performance outcome variables. At 17 weeks of age,
male aspartame-fed mice exhibited weight gain, elevated fasting glucose levels and decreased insulin sensitivity compared
to controls (P,0.05). Females were less affected, but had significantly raised fasting glucose levels. During spatial learning
trials in the MWM (acquisition training), the escape latencies of male aspartame-fed mice were consistently higher than
controls, indicative of learning impairment. Thigmotactic behavior and time spent floating directionless was increased in
aspartame mice, who also spent less time searching in the target quadrant of the maze (P,0.05). Spatial learning of female
aspartame-fed mice was not significantly different from controls. Reference memory during a probe test was affected in
both genders, with the aspartame-fed mice spending significantly less time searching for the former location of the
platform. Interestingly, the extent of visceral fat deposition correlated positively with non-spatial search strategies such as
floating and thigmotaxis, and negatively with time spent in the target quadrant and swimming across the location of the
escape platform. These data suggest that lifetime exposure to aspartame, commencing in utero, may affect spatial cognition
and glucose homeostasis in C57BL/6J mice, particularly in males.
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Introduction
Previous studies have shown that chronic consumption of the
dipeptide artificial sweetener aspartame may affect the T-maze
cognitive performance of male rats, promoting impairment of
retention of learned behavior when compared to the performance
of controls [1]. The Acceptable Daily Intake for aspartame
currently stands at 50 mg/Kg body weight in the United States,
and 40 mg/Kg in Europe. Once ingested, aspartame (L-aspartyl-
phenylalanine methyl ester) is rapidly metabolized to its metabolic
components phenylalanine, aspartate, and methanol in the ratio of
50:40:10 w/w/w [2]. Whilst the neurological effects of methanol
have been well documented, [3] aspartate, like glutamate, has
been shown to cause brain lesions [4], obesity [5] and impaired
memory retention [6] in rodents exposed to these excitatory amino
acids (EAA).
The aspartame metabolite phenylalanine is an essential amino
acid which occurs naturally in the breast milk of mammals;
however high levels of phenylalanine are a health hazard to those
born with phenylketonuria (PKU), a metabolic disorder caused by
an inherited mutation in the phenylalanine hydroxylase (PAH)
gene which prevents phenylalanine from being metabolized
correctly. This results in a detrimental accumulation of the amino
acid, leading to developmental defects, seizures and mental
retardation [7]. Normal mammalian plasma levels of phenylala-
nine are approx. 30–50 mM (0.5–0.8 mg/dL), however 1 in 50
individuals are heterozygous for the mutation in the phenylalanine
hydroxylase gene [8], resulting in significantly higher levels of
fasting plasma phenylalanine compared to non-carriers [9],
together with a reduced phenylalanine clearance rate after
intravenous loading [10]. Repeated ingestion of 8 servings of
aspartame-sweetened beverages by PAH heterozygous individuals
incurred plasma phenylalanine levels of up to 165 mM [11],
although this was still well below the levels reported to cause
neurotoxicity during acute administration in primates. Addition-
ally, genetically mutated PAH-deficient homozygous Pah
enu2 PKU
BTBR mice have six times the level of brain phenylalanine
compared to their heterozygous counterparts [12], resulting in
abnormal CNS synapses and dendritic spines [13] together with
pathological cognitive impairment [14]. In vitro, phenylalanine has
been demonstrated to specifically and reversibly attenuate
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of      the    glutamatergic synaptic transmission by competing with the glycine
binding site of N-methyl D-aspartate (NMDA) receptor [15,16].
Additionally, the ratio of GluN2A/GluN2B NMDA receptor
subunit expression is significantly increased in the hyperphenyl-
alaninemic Pah
enu2 PKU mouse model, suggesting a potential
mechanism whereby elevated levels of phenylalanine may impair
brain development and function [12,17]. Since their discovery in
the early 1950s, NMDA receptors have been implicated in many
crucial functions of central importance, including learning and
memory, neuronal plasticity and neurotoxicity [18,19]; and they
are the only known receptor that is regulated both by a ligand
(usually glutamate) and also by voltage [20]. There are at least five
binding sites on the NMDA receptor which regulate its activity
including glutamate, glycine, magnesium, zinc and a fifth site that
binds to the hallucinogenic substance phencyclidine [21]. The
central role of NMDA receptors in the process of learning and
memory has been confirmed by the extensive use of NMDA
receptor agonists and antagonists to study long term potentiation
in memory acquisition and maintenance [22].
Whereas it is generally agreed that aspartate crosses the
placenta only to a limited degree [23], phenylalanine is actively
transported across the placenta [24], resulting in an increase in this
aromatic amino acid at the expense of the maternal concentration
[25]. During pregnancy, aspartame administration by gavage
resulted in impaired performance of the offspring in an odor-
aversion test administered to guinea-pigs within the first month of
life [26]. This insightful study confirms previous reports in a
second species, that aspartame administered pre- and postnatally
to rats can result in impaired cognitive performance of the
offspring [27]. Furthermore, aspartame has been shown to cause
brain inflammation, hyperglycemia and fatalities in a third species:
the hyperlipidemic zebrafish model [28]. Aspartame-fed zebrafish
also exhibited swimming defects which were interpreted as
possibly due to damage in the brain and neurons (28).
The timing, dosage and route of EAA administration in vivo
appears to be of critical importance, since acute exposure to high
doses of dipeptide aspartame during adulthood has no effect on
cognitive ability in either humans [29] or rodents [30]. However a
single i.p. injection 500 mg/Kg aspartate was sufficient to cause
memory impairment and neuronal damage in adult mice
undergoing passive avoidance testing [6]; and intracranial
injections of phenylalanine caused permanent amnesia in 1 day
old chicks [31]. Similarly, perinatal exposure to glutamate results
in delayed onset neuroendocrine dysfunction together with
cognitive deficiencies [32–38], whereas exposure to considerable
amounts of dietary glutamate in adulthood is apparently without
effect [39]. Interestingly, we [40] and others [41] have noted
gender-specific differences in behavior in response to Monosodium
Glutamate (MSG). Gender dimorphism in MSG-induced impair-
ment of the growth hormone / IGF-1 axis has also been
investigated [42], and it would be of interest to ascertain whether
gender dimorphism in glucose homeostasis exists in response to
aspartame consumption.
The aims of the present study were therefore to examine the
effect of lifetime exposure to aspartame, commencing in utero,o n
weight gain, spatial cognition, insulin sensitivity and glucose
parameters of male and female C57BL/6J mice. We used a
dosage of aspartame which approximated the ADI for aspartame
in the US (approx. 50 mg/kg body weight). Insulin sensitivity was
assessed by a random fed insulin tolerance test (ITT), together with
measurements of fasting glucose and insulin levels; and cognitive
performance was assessed in the Morris Water Maze (MWM). The
relationship between visceral fat deposition and cognitive function
was determined by analyzing the correlation between body
characteristics, glucose and insulin parameters and performance
targets in the MWM test, using Pearson correlation analysis.
Materials and Methods
Animals and Diets
C57BL/6J mice of both sexes were obtained from the Jackson
Laboratory and housed/caged in a controlled environment (3 to a
cage in pathogen-free conditions of 12 h light/dark cycle,
2262uC) and fed a standard chow diet with water ad libitum until
6 weeks of age. The two diet groups used in this study were (1) ad
libitum Standard Chow (Control diet) with ad libitum drinking
water. (2) Ad libitum Standard Chow, with ad libitum drinking water
containing 0.25 g/L aspartame as the only source of drinking
water (Asp-Phe methyl ester, catalog A5139 Sigma Aldrich). After
a 3-week period of adjustment, male and female mice were bred,
weaned and maintained on these respective diets for the times
stated. Mean body weight was assessed at 6 and 17 weeks of age.
Food and water intake was assessed at 7 weeks and again at 15
weeks of age, in pre-weighed mice over a four day period, by
weighing the food pellets and water bottles to the nearest 0.1 g.
Mean food/water consumption was calculated by subtraction, and
expressed as g/20 g body weight (bw) and mls/20 g bw
respectively. Mean aspartame consumption was calculated from
the amount of aspartame-water consumed, and expressed in mg
per Kg bw. Body length to the nearest mm was assessed at 6 and
17 weeks of age using a woven tape measure. The breeding and
care of the animals were in accordance with the protocols
approved by the Animal Care and Use Committee of the King
Faisal Specialist Hospital & Research Centre. At the conclusion of
the study, animals were humanely euthanized with a mixture of
xylazine and ketamine (10 mg/kg and 100 mg/kg respectively);
and the liver and visceral fat were carefully dissected out and
removed, rinsed twice in PBS, blotted dry and weighted to the
nearest 0.01 g. These tissues were rapidly snap-frozen for use in
further studies.
Measurement of Fasting Serum Glucose, Insulin and Lipid
Profile
Overnight fasting blood glucose was measured using the
Ascensia Contour glucometer (Bayer HealthCare, IN, USA).
Fasting serum insulin was measured using the mouse insulin
ELISA kit from Millipore/Linco (Uppsala, Sweden). Homeostatic
Model Assessment Index (HOMA-IR) values, a measure of insulin
resistance, were calculated according to the established formula:
(fasting serum insulin mIU/ml) * (fasting serum glucose mM)/22.5
[43]. Serum Triglyceride (Tg), total cholesterol (T-CHOL), and
HDL-C concentrations were measured in overnight fasted mice
using the Reflovet Plus instrument (Roche, F. Hoffmann-La
Roche Ltd, Basel, Switzerland) as previously described [40].
Morris Water Maze (MWM) Testing Apparatus
The spatial learning abilities of the C57BL/6J mice were
assessed at 16 weeks of age (mature adulthood) in a MWM task
[44], since our previous studies indicate that this is the optimal
time for assessing the effect of dietary interventions on cognitive
behavior [40]. The apparatus consisted of a white circular pool of
150 cm diameter and 50 cm height, filled with water made
opaque by the addition of a small amount of non-toxic white paint
(30 cm deep) and maintained at 21–22uC. A circular escape
platform (11 cm in diameter) was placed in a fixed South-West
location hidden 0.5 cm below the surface of the water, and 3
stationary geometric visual cues were kept in the room throughout
the period of testing as previously described [40]. A digital camera
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tracking system in order to record the performance of the
experimental subjects (HVS Image Analysis VP-200, HVS Image,
Hampton, UK).
MWM Procedure: Assessment of Learning abilities
Mice were given four consecutive days of acquisition training
sessions that consisted of four trials per day with an inter-trial
interval of 20 minutes. In order to investigate the effect of diet on
allocentric spatial reference memory, the position of the hidden
platform remained fixed however the entry point was pseudo-
randomly selected from one of the 4 compass locations each
day, and the same sequence of starting points was used for all the
mice tested. Mice were given 120 seconds to find the platform and
if the subject failed to locate the platform within this period, it was
guided onto it. All mice were allowed to rest on the platform for a
30 second interval after each trial. At the end of the training block,
mice were put in a pre-warmed drying cage and allowed to dry
prior to being returned to their experimental cages.
MWM Escape Strategies Analysis
During the acquisition phases of learning, mice adopt a number
of increasingly sophisticated escape strategies as part of allocentric
spatial memory acquisition [45]. Initial strategies such as
thigmotaxis and random searching which do not involve any
spatial or directional preference progress to strategies usually
described as scanning (directionless searching of the interior
portion of the pool), chaining (circular swimming at an
approximately fixed distance greater than 16 cm from the wall),
followed by directed searching for the escape platform.
MWM Probe Test for Spatial Memory Assessment
A Probe Test was run on day 5, after 4 days of acquisition.
Before the probe test, the hidden platform was removed and the
mouse was introduced from the north quadrant, where it was left
to search for the platform for 60 seconds. Time spent in the target
quadrant, number of platform crossings, and annulus crossing
index (ACI: defined as the number of crosses over the platform
position in the target quadrant, relative to crosses over the
corresponding platforms in the remaining three quadrants) were
recorded.
Random-fed Insulin Tolerance Test (ITT)
The effect of aspartame on glucose parameters was determined
using a random-fed insulin tolerance test (ITT) administered to 19-
week old mice. Because swimming exercise has been shown to
alter insulin sensitivity and glucose homeostasis [46], we
performed the ITT on additional mice who had not been
subjected to the water maze protocol (n=18 per diet / gender
group). For the ITT, an intraperitoneal injection of insulin (Sigma,
IL) at a dose of 0.75 U/kg body weight was administered, and
whole blood glucose levels were measured from the tail vein at 0,
15, 30, 45 and 60 minutes after injection.
Data Analysis
Data were presented as mean 6SEM for body-weight, serum
lipid profile, glucose and insulin variables separately in male and
female mice. For statistical comparisons between the two diet
groups, unpaired Student’s t test was applied using Graph Pad
Instat software (version 3, California, USA). For the MWM
experiments, the following variables characterizing the perfor-
mance of mice in the MWM were chosen for analysis: Latency,
defined as time taken (in seconds) for a mouse to reach and climb
the platform, and the length of each Swim Path (in meters).
Locomotor activity was analyzed using the average Swim Speed
(M/s), and the percent of time that the animals were relatively
stationary (with swim speed below the 0.06-m/sec threshold) was
recorded as Floating Time (%). Thigmotaxic swimming activity
Table 1. Effect of aspartame consumption on weight gain, adiposity, glucose homeostasis and lipid profile.
Male Female
Control Aspartame Control Aspartame
Body Weight (6 weeks) 17.6 6 0.13 17.22 6 0.35 14.31
11 6 0.17 14.34
11 6 0.22
Body Weight (17 weeks) 24.02 6 0.48 24.96 6 0.4 18.91
11 6 0.21 19.42
11 6 0.27
% Weight Gain 36.42 6 2.44 45.31* 6 2.71 32.3 6 1.45 35.63
11 6 1.5
Length (cm) 9.65 6 0.08 10.04** 6 0.08 9.21 6 0.07 9.52**
11 6 0.06
Visceral Fat (g) 0.09 6 0.02 0.24** 6 0.02 0.08 6 0.01 0.13**
11 6 0.01
RW of Visceral Fat (g/20g BW) 0.08 6 0.01 0.192** 6 0.02 0.09 6 0.01 0.13**
11 6 0.01
Liver Weight (g) 0.89 6 0.02 1.03* 6 0.06 0.76 6 0.03 0.71
11 6 0.02
RW of Liver (g/20g BW) 0.75 6 0.02 0.82 6 0.04 0.81 6 0.03 0.736* 6 0.02
Fasting Glucose (mM) 3.1 6 0.18 4.61** 6 0.43 2.93 6 0.13 3.65**
1 6 0.17
Fasting Insulin (uIU/ml) 17.32 6 2.54 16.67 6 1.86 10.37
1 6 0.8 8*
11 6 0.58
HOMA-IR 2.36 6 0.35 3.19 6 0.24 1.35
1 6 0.11 1.29
11 6 0.1
TG (mg/dL) 104.17 6 7.42 107.41 6 5.88 123.25 6 6.67 98.24* 6 6.32
T-CHOL (mg/dL) 121.5 6 1.08 121.08 6 1.4 121.92 6 0.91 122 6 0.46
HDL-C (mg/dL) 77.13 6 3.55 63.25** 6 3.04 54.47
11 6 2.73 41.45**
11 6 2.23
LDL (mg/dL) 23.54 6 3.10 36.34* 6 3.42 42.80 6 2.63 60.89**
11 6 2.41
BW, Body Weight; RW, Relative weight.
Data presented are means 6 SEM, n=12 per group. P-value ,.05 and , 0.01 based on t-test comparisons of diet groups within sexes are indicated by * and **; and
comparison of sexes by 1 and 11 respectively.
doi:10.1371/journal.pone.0031570.t001
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within a 16-cm distance from the wall. Spatial cognition of the
platform location during acquisition trials and during the probe
day was evaluated by the analysis of the dwelling time in each of
the pool’s quadrants. Overall treatment effects were examined
using a repeated measures generalized linear model using SPSS
13.0 statistical software (SPSS Inc., Chicago, IL). For the analysis
of the escape strategies, the Swim Paths for each mouse was
plotted and categorized into one of the following search
strategies:(1) Direct swim towards the location of the platform;
(2) Directed search, in which the animal swims in a search
pathway directly towards the platform; (3) Focal search: searching
in the quadrant containing the hidden platform. (4) Scanning,
where the search path is restricted to a limited, often central, area
of the pool; (5) Random searching in which the animal swims over
the entire area of the pool. (6) Chaining, which is circular
swimming at a fixed distance from the wall; (7) Thigmotaxis (wall-
hugging swim): a persistent swim along the outer 16 cm of the
pool. (8) Floating: a state of inactivity without forward movement.
The use of each search strategy was presented as a percent of
incidences during each trial over the whole analyzed experimental
period.
Results
Effect of Aspartame on Weight Gain, Blood Glucose and
Insulin Parameters
Averaged aspartame ingestion in the drinking water was
55.1464.74 mg/Kg body weight. Water and food consumption
were unaffected by the addition of aspartame compared to
controls (data not shown). Weight gain was significantly higher in
the male aspartame diet group compared to controls (Table 1,
P=0.024), but female weight gain was unaffected by diet. Body
length and visceral fat deposition were both increased in
aspartame-fed mice of both sexes (Table 1, P,0.01). Females
weighed less than males, and had less fat deposition following
aspartame treatment, although there was no difference between
the absolute or relative weight of the visceral fat collected from
control animals. Liver weight was affected by diet as well as
gender, with livers from aspartame-fed males weighing more than
control males; and more than those of female aspartame-fed mice
(P,0.05 and P,0.01 respectively). Additionally, aspartame-fed
mice had elevated fasting blood glucose levels compared to non-
consumers of both sexes, although females had lower levels than
males (Table 1, P,0.01). Fasting insulin and HOMA-IR levels in
female mice were significantly lower than males, although all were
within the normal range (Table 1). Pearson correlation analysis
was used in order to examine associations between body weight,
fat deposition, indices of glucose homeostasis and lipid profile. As
expected, body weight at six weeks of age strongly correlated with
weight at 17 weeks (Table 2, r=0.888, P,0.001). We also found
correlations between weight gain and visceral fat, body length,
fasting glucose, insulin and HOMA-IR (Table 2, r=0.322, 0.546,
0.440, 0.371 and 0.548 respectively, P,0.01).
A Random-fed insulin tolerance test administered at 19 weeks
of age showed that glucose levels in male aspartame-fed mice
were 120.2% higher than control mice following insulin challenge
(Fig 1A, P=0.001); and remained significantly elevated above
controls for up to 30 minutes, suggesting impairment of glucose
and insulin regulation. The mean Area Under the Curve (AUC)
in male aspartame-fed mice was significantly higher than control,
suggesting deregulation of glucose homeostasis (Table 3:
5829.796197.72 mU/L/60 min vs 4829.586131.96 mU/L/
60 min: P,0.001), Mean AUC in female mice showed a similar
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60 min vs 4819.936190.36 mU/L/60 min). The half-life of
glucose in the aspartame mice showed a non-significant trend
towards elevation compared to control (Table 3). Collectively
these data indicate that aspartame treatment affects C57BL/6J
weight gain (6–17 weeks of age), visceral fat deposition and
glucose homeostasis particularly in males, and to a lesser extent in
females.
Figure 1. Aspartame consumption reduces insulin sensitivity of male C57BL/6J mice during a random-fed insulin tolerance test.
Values are mean6SEM of (A) male glucose levels and (B) female glucose levels, n=18 per group, *** P,0.001 compared to controls.
doi:10.1371/journal.pone.0031570.g001
Table 3. Effect of aspartame consumption on blood glucose levels during a random–fed insulin tolerance test.
Control Aspartame P-value
Males
AUCtotal (mM x min) 4829.58 6 131.96 5829.79 6 197.07 ,.001
Kglucose (%/min) 2.92 6 0.28 2.32 6 0.29 0.15
TK (min) 39.69 6 14.05 51.61 6 16.63 0.59
Females
AUCtotal (mM x min) 4819.93 6 190.36 5194.63 6 208.04 0.19
Kglucose (%/min) 2.71 6 0.37 2.24 6 0.26 0.31
TK (min) 34.19 6 4.4 23.28 6 9.59 0.31
AUC, area under the curve; K, clearance rate; TK, half-life.
Values are means6SEMs, n=18 per group.
doi:10.1371/journal.pone.0031570.t003
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Spatial learning strategies in the MWM. During the
acquisition phase of the MWM testing (days 1 to 4), significant
differences in place learning performance of aspartame-fed mice
became apparent. Cued escape latencies across sessions of mice
from both diet groups are shown in Fig 2. All mice improved their
performance over the 4 days of training, however, latencies of
male aspartame-treated mice were higher than control latencies on
the last 2 days of the 4-day trial (Fig 2A, P,0.05), suggesting that
aspartame may have impaired learning (acquisition) skills in these
mice. Female aspartame-fed mice had similar latencies to non-
consumers (Fig 2B). The duration of time spent in the target
quadrant where the hidden platform was located is shown in
figure 2C (males) and 2D (females). As testing progressed, mice
learned to spend more time searching for the platform within the
target quadrant, but aspartame-fed males spent significantly less
time searching for the platform in the target quadrant (Fig 2C,
P,0.05). A comparison of mean distance (in meters) to reach the
goal platform showed that aspartame-fed mice were farther from
their goal than controls on all four days of acquisition training,
suggestive of impaired learning (Fig 2E, P,0.05). Swim speed was
unaffected by diet (data not shown).
Floating and thigmotaxis behavior. To gain further insight
into the reduced spatial learning of aspartame-fed mice, we studied
the non-spatial behavioral parameters of these mice and that of
controls. Floating behavior, characterized by periods of immobility
and defined as percent of time with swim speed below a 0.06m/sec
threshold, revealed a significant effect of diet during the
acquisition period, with male aspartame-fed mice exhibiting
increased floating behavior on days 2,3 and 4 compared to
controls (Fig 3A, P,0.001). Thigmotaxis, defined as percentage of
Figure 2. Effect of aspartame consumption on spatial learning in C57BL/6J mice: gender-specific differences. Acquisition curves of
escape latency in male (A) and female (B) aspartame-fed and control diet mice. Percentage time spent in target quad in male (C) and female (D) mice.
Mean Distance to goal in male (E) and female (F) mice. Each group consisted of 12 mice; * P,0.05, ** P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0031570.g002
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increased in aspartame-treated males throughout the whole
experiment (Fig 3C, P,0.01), whereas female thigmotactic
behavior decreased throughout the acquisition period, and
showed no diet effect. Taken together, our data suggests that
males exposed to chronic dietary aspartame had impaired spatial
learning abilities together with increased non-spatial strategies.
Effects of aspartame on qualitative aspects of
learning. To assess the effect of diet on qualitative aspects of
learning which could account for the apparent differences in
latency, we analyzed the respective search strategies displayed by
the mice to locate the hidden platform on the four days of
acquisition training. As the training progressed, control male and
female mice spent increasing amounts of time in directed
searching and direct swimming towards the platform, in addition
to using other strategies which require spatial and directional
searching, including focal searching (Fig 4A,B). Non-spatial
behavior, such as thigmotaxis and floating, decreased during the
4 days of training such that by Day 4, male control mice spent no
time either swimming around the periphery of the maze, or
floating directionless. Conversely, compared to control,
aspartame-fed mice exhibited significantly less time acquiring
spatial and directional strategies to find the hidden platform
during the acquisition training (Fig 4B, P,0.05).
Effect of aspartame on spatial memory in the MWM
Probe Test. Regardless of gender, diet-induced differences in
spatial retention were apparent during a probe test, the recognized
measure of spatial memory, performed after the 4 days of
acquisition training. Once the platform had been removed,
aspartame-fed mice of both genders spent significantly less time
swimming towards the former position of the hidden platform
compared to control, (Fig 5A & B, P,0.05). Additionally, male
aspartame-fed mice crossed the former location of the platform
significantly less frequently than controls (Fig 5 C, P,0.01), and
had a lower Annulus Crossing Index (Fig 5E, P,0.01), implying
impairment of spatial memory. Platform crossing and annulus
crossing indices of female mice showed a similar trend without
reaching statistical significance (Fig 5 D & F). Overlapping swim
paths (n=12) of aspartame-fed and control male and female mice
are shown in figure 5 G & H. The location of the hidden platform
can be visualized through the aspartame-mice swim path,
indicating that the animal did not frequently cross the location
of the platform during the trial.
To complete our analysis of the performance of the mice during
this water maze test, we next used repeated measures generalized
linear modeling analysis of MWM performance variables
throughout the 4 days of acquisition training and during the
probe test, in males and females consuming the aspartame diet
compared to controls (Table 4). In males, significant differences in
floating and thigmotactic behavior between controls and aspar-
tame-fed mice were apparent on four out of the five days of testing,
and the mean distance to goal (a measure of how close mice swam
towards the platform) was significantly different between the two
diet groups on all days of testing (P,0.05). The performance of
females however, was only significantly different on the last day of
acquisition training and during the probe test.
Figure 3. Effects of aspartame consumption on non-cognitive behavior. Percentage of time spent floating in male (A) and female (B)
aspartame-fed and control diet mice. Thigmotaxis in male (C) and female (D) mice, n=12 per group; * P,0.05, ** P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0031570.g003
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In order to understand more about the possible mechanisms
behind the reduction in escape latencies in aspartame-fed mice, we
next examined correlations between body characteristics and
MWM performance indicators (Table 5). Surprisingly visceral fat
deposition correlated positively with floating time on all days of the
trials, and also with thigmotaxis on day 3,4 and the day of the
probe test (P,0.05). Fat deposition also correlated with escape
latency time on these days, and negatively with time spent in the
target quarter, platform crossings and ACI. Finally, in order to
validate our analysis, we performed correlation analysis on all
MWM outcome variables in all mice analyzed simultaneously. As
expected, we found a strong negative correlation between latency
and floating time and between latency and mean distance to goal
(Table S1). Escape latency also correlated negatively with time in
target quadrant, number platform crossings, and the ACI. Taken
together, these correlations suggest that our analysis is valid, and
lends credence to observations concerning adiposity and non-
spatial learning strategies.
Discussion
Our results suggest that neonatal exposure to aspartame
consumed as part of the diet of pregnant mice, together with
continued chronic exposure of the offspring to dietary aspartame
throughout the first 20 weeks of life, may result in increased weight
gain compared to controls together with impairment of insulin
sensitivity and cognitive performance, most notably in males. Food
and water intake was not affected by aspartame administration
within the ADI. The results of our analysis support previous
observations that aspartame may cause impairment in learning
and memory particularly when administered chronically [1,47] or
neonatally [26]. Additionally, damage to hypothalamic morphol-
Figure 4. Effects of diet and gender on spatial and non-spatial escape strategies during the MWM test. (A) Orientation of entry point
and escape platform on trial days 1–4. Arrows indicate location of entry point. (B) Distribution of search strategies in aspartame-fed mice compared to
controls on trial days 1–4. As the acquisition training advanced, control C57BL/6J mice exhibited progressive behavioral changes from random
chaining, thigmotaxis and floating into predominantly spatial strategies such as direct swim and direct search. Mice in the aspartame group exhibited
less spatial strategies and more non-spatial behavior throughout the trials.
doi:10.1371/journal.pone.0031570.g004
Aspartame-Induced Impairment of Spatial Cognition
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e31570ogy has been reported in neonatal rodents ingesting high amounts
of aspartame [48].
Aspartame is metabolized rapidly into methanol, phenylalanine
and aspartate [2]; and oral administration of aspartame (200 mg/
Kg) has been shown to increase levels of rat brain phenylalanine
and its metabolite tyrosine, whilst decreasing levels of leucine,
isoleucine and valine [49]. Whereas it is generally accepted that
aspartate does not readily cross the placenta, phenylalanine and
tryosine are readily transported to the fetal tissues; resulting in an
increase in phenylalanine at the expense of the maternal
concentration [25]. In rodents, phenylalanine is readily converted
into the neurotransmitter precursor tyrosine by the hepatic
enzyme PAH [50]; however if the activity of this enzyme is
reduced or absent, the high levels of accumulated phenylalanine
Figure 5. Results from a probe trial intended to measure spatial memory. Percentage of time spent searching in the former location of the
platform (Target Quad) in (A) males and (B) females, compared to time spent in the adjacent quads. Aspartame-fed males showed a reduction in the
number of times they crossed over former location of the platform (C: Platform Crossings and (E: Annulus Crossing Index), n=12 per group, * P,0.05,
** P,0.01, *** P,0.001. There was no significance in the reduction of platform crossings and Annulus Crossing Index in females. Actual overlapping
swim paths of the control (G,I) and aspartame-fed mice (H,J). Swim paths illustrate less intense swimming in the location of the platform by
aspartame-fed mice, compared to controls.
doi:10.1371/journal.pone.0031570.g005
Aspartame-Induced Impairment of Spatial Cognition
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e31570may be converted into other metabolites such as phenylpyruvate,
phenylacetate and phenyllactate [50,51]. Crucially, studies have
shown that in rodents, PAH activity is undetectable until the final
days of gestation and birth, whereupon the gene is activated by
glucocorticoids and cyclic AMP [52–54]. Experimentally induced
hyperphenylalaninemia has been shown to result in spatial and
non-spatial deficits in cognition and learning that are not related to
impairment of locomotor skills [55,56]. In humans, deficiency of
PAH due to genetic mutations in the gene results in phenylketon-
uria (PKU), which is characterized by neurotoxic hyperphenylal-
aninemia and microcephaly, together with visuo-spatial, executive
and attention deficits [57,58]. The mechanisms responsible for the
hyperphenylalaninemia-induced brain damage are still largely
unknown; however hyperphenylalaninemia has recently been
shown to promote oxidative stress in rodent brains, which may
contribute to the neurotoxicity in phenylketonuria [59,60].
Oxidative stress is the result of the aberrant production of reactive
oxygen and / or nitrogen species, or a decrease in the capacity of
antioxidant defenses for example glutathione; and has been linked
to a number of neurodegenerative diseases and to the cognitive
decline associated with aging [61]. Importantly, subcutaneous
injections of aspartame have recently been shown to increase rat
brain thiobarbituric acid-reactive substances (TBARS; markers of
lipid peroxidation) and decrease glutathione levels [62]. Collec-
tively, these observations may provide clues as to a mechanism
whereby aspartame metabolites; phenylalanine in particular, may
contribute to the impairment in spatial learning and memory that
we observed in mice exposed to aspartame in utero and during the
first months of life.
During acquisition of the water maze task, young rodents
typically improve their performance as indicated by a progressive
reduction in escape latencies over successive training sessions.
Upon introduction to the maze, mice initially adopt non-spatial
behaviors including thigmotaxis, scanning and chaining [45,63].
As training progresses, this behavior gives way to spatial learning,
resulting in more cued swimming towards the hidden platform,
more time spent in the target quadrant, and shorter escape
latencies. Within the context of this paradigm, aspartame-fed mice
exhibited significant differences in learning strategies at four
months of age, which resulted in longer escape latencies compared
to controls, together with quantitative and qualitative differences
in behavioral strategies employed. Towards the end of acquisition
training, aspartame-fed mice spent significantly more time
swimming around the periphery of the pool and passively floating
compared to control mice, which may be indicative of an
ineffectual non-spatial swim strategy [64]. Increased thigmotaxis
behavior linked to a deficit in responding to visual cues has
previously been noted after experimentally induced lesions to the
dorsal-striatum: a compound structure of the brain believed to be
involved in stimulus-response learning [65]. Additionally, lesions
to the hippocampus [66] and NMDA receptor blockade using
specific antagonists have also shown to result in increased
thigmotactic behavior [67,68].
Impairment of spatial memory in the aspartame diet group was
suggested by a significant reduction in time spent swimming
towards the former platform location during the probe test.
Additionally, thigmotactic behavior and passive floating during the
probe test was increased in male aspartame-fed mice compared to
controls. Taken together this suggests that chronic exposure to
aspartame may impair rodent spatial memory. It has previously
been suggested that exposure to high doses of aspartame at a late
stage of pregnancy may result in a delay in visual placing response
in the offspring, which is a measure of sensorimotor activity [69].
However, a second study failed to duplicate these findings [70].
In addition to the effects of aspartame on rodent cognitive
performance in the water maze, aspartame appeared to raise
fasting blood glucose levels in both sexes. The relationship
between peripheral blood glucose levels and cognition has been
Table 4. Generalized linear modeling of performance variables in aspartame-fed C57BL/6J mice compared to controls.
Day 1 Day 2 Day 3 Day 4 Probe Test
Males
Latency 0.862 0.061 ,.001 ,.01 ,.001
Thigmotaxis time (%) ,.01 ,.01 ,.0001 ,.0001 0.236
Floating time (%) 0.348 ,.01 ,.001 ,.001 ,.05
Mean distance to goal (m) ,.05 ,.05 ,.001 ,.001 ,.05
Time in target quadrant (%) ,.01 0.076 ,.05 0.112 0.112
Time in non-target quadrants (%) ,.01 0.076 ,.05 0.112 0.111
Platform Crosses 0.715 0.547 ,.001 0.800 ,.001
Annulus Crossing Index 0.781 0.569 ,.01 0.553 ,.001
Females
Latency 0.817 0.359 0.644 0.090 0.474
Thigmotaxis (% time ) 0.623 0.957 0.452 ,.05 0.818
Floating (% time) 0.191 0.347 0.640 ,.01 0.175
Mean distance to goal (m) 0.626 0.822 0.291 ,.05 ,.05
Time in target quadrant (%) 0.321 0.897 0.605 0.176 ,.05
Time in non-target quadrants (%) 0.321 0.895 0.602 0.175 ,.05
Platform Crosses 0.225 0.339 0.650 0.153 0.277
Annulus Crossing Index 0.263 0.536 0.290 0.619 0.199
Significant differences in performance between the control and the diet groups are indicated in bold P-value # 0.05, for trial days 1 to 4 and probe day, n=12 per
group.
doi:10.1371/journal.pone.0031570.t004
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neuroglycemic range within which optimal cognitive function
occurs [71]. Hyperglycemia may damage the microvasculature of
the blood-brain barrier and/or modify insulin availability in the
brain, disrupting normal brain function and cognition. Interest-
ingly hyperglycemia, increased body weight and swimming defects
were recently observed in hyperlipidic zebrafish exposed to
aspartame [28], which tends to support our present observations.
However, our data using doses of aspartame approximating the
current ADI contrasts with a previous report which concluded that
long term consumption of aspartame from six weeks onwards did
not increase weight gain [72]. This apparent contradiction could
conceivably be due to the fact the aspartame in that toxicology
study was administered from the 6
th week of life onwards at a dose
of 2–4 g/Kg body weight (40–80 times the current ADI), resulting
in a significant reduction in food intake for animals consuming the
higher quantity of the dipeptide sweetener. Interestingly human
studies have found a positive correlation between the consumption
of artificial sweeteners and weight gain [73,74]; and surprisingly in
diabetic subjects, aspartame-containing meals elevated blood
glucose and insulin levels to the same extent as that of higher-
calorie sucrose-containing meals [75].
A third novel observation in our study relates to gender-specific
differences in insulin sensitivity and cognitive performance, with
males apparently exhibiting a greater adiposity, weight gain,
glucose dysregulation and cognitive impairment compared to
females. Gender-specific differences in behavior have also been
documented in response to Monosodium Glutamate (MSG) a
commonly consumed food additive. MSG-treated males appear to
be more adversely affected than females [41,76], and have a
greater increase in adipose tissue deposition [77] and insulin
resistance [34] than females. Therefore the possibility exists that
although both males and females showed equal increases in fasting
glucose levels in response to aspartame, the gender-specific
differences in cognitive performance may be due to differences
in the extent of adiposity and insulin resistance, both of which are
associated with cognitive performance [78]. A final intriguing
outcome from our study was the correlation we found between
Table 5. Summary of correlation analysis between body characteristics and spatial memory variables in the MWM test.
% weight
gain
Body Weight
(g)
Visceral Fat
(g)
Insulin
(uIU/ml)
Glucose
(mM) HOMA-IR
T-CHOL
(mg/dL)
HDL-C
(mg/dL) LDL (mg/dL)
Latency (s)
Day 2 0.027 20.092 0.005 0.095 0.050 0.132 0.242 20.054 0.094
Day 3 0.232 0.075 0.357* 0.023 0.246 0.148 0.191 20.065 0.130
Day 4 0.063 0.029 0.428** 20.076 0.124 0.010 0.195 20.070 0.139
Probe Test 0.211 0.076 0.431** 0.017 0.207 0.150 20.116 20.257 0.281*
Thigmotaxis time (%)
Day 2 0.290* 0.113 0.265 0.085 0.187 0.195 0.097 0.053 20.025
Day 3 0.327* 0.263 0.488*** 0.002 0.409** 0.255 0.206 0.169 20.108
Day 4 0.163 0.291* 0.553*** 0.046 0.396** 0.240 0.048 0.094 20.020
Probe Test 20.010 0.211 0.356* 0.001 0.259 0.133 0.061 0.123 20.097
Floating Time (%)
Day 1 20.157 0.046 0.402** 20.115 20.045 20.089 0.096 0.088 20.058
Day 2 20.103 20.052 0.340* 20.134 0.174 0.005 0.111 20.074 0.104
Day 3 0.086 0.062 0.487*** 20.224 0.369** 0.006 0.278* 20.045 0.158
Day 4 0.162 0.054 0.441** 20.128 0.349* 0.076 0.214 20.035 0.156
Probe Test 0.258 0.188 0.457** 20.077 0.433** 0.177 0.202 0.012 0.074
Time in Target Quadrants (%)
Day 1 20.164 0.075 20.284* 0.136 20.234 20.024 20.164 0.158 20.230
Day 2 20.245 20.224 20.188 20.361* 20.078 20.355* 20.188 20.102 0.086
Day 3 20.137 20.162 20.349* 20.135 20.021 20.121 20.056 0.037 20.041
Day 4 20.085 20.243 20.294* 20.193 20.302* 20.330* 0.167 0.024 0.048
Probe Test 20.054 0.160 20.134 20.057 20.002 20.055 20.114 0.347* -0.368**
Platform Crosses
Day 2 20.028 0.130 0.071 20.020 20.010 20.034 20.387** 0.034 20.122
Day 4 20.122 0.002 20.369** 0.094 20.260 20.051 20.160 0.079 20.146
Probe Test 20.265 20.120 20.401** 0.023 20.157 20.080 20.005 0.223 20.221
ACI
Day 3 20.188 20.118 20.384** 20.051 20.182 20.131 20.030 0.042 20.073
Day 4 20.133 20.199 20.275* 20.173 0.060 20.125 20.161 20.118 0.079
Probe Test 20.213 20.027 20.359* 20.004 20.074 20.052 0.048 0.317* 20.303*
Significant correlations are shown in bold with *, ** and *** indicating a P-value of #.05, #.01 and #.001 respectively, n=12 per group
doi:10.1371/journal.pone.0031570.t005
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(thigmotaxis and floating behavior) during the MWM test. In
general, non-spatial behavior in the MWM test is associated with
an inability to adopt spatial cognitive abilities [79], and others
have found that high-fat diets which promote obesity also impair
spatial memory in rodents [80,81].
Our study terminated when the mice were 20 weeks of age
(mature adulthood); however it would be of interest to ascertain
whether the effects that we noted resulting from lifetime exposure
to aspartame will still be apparent in an aging mouse model. Our
unpublished observation, together with previous studies [81]
suggests that the water maze performance of older C57Bl/6J mice
decreases markedly with aging. Further studies are warranted to
assess the effects of aspartame on metabolism and cognition in
aging mice, and in mice from different strains. In conclusion, we
have demonstrated that compared to controls, neonatal exposure
of rodents to dietary aspartame, combined with chronic aspartame
consumption throughout early life, may result in impairment of
glucose and insulin homeostasis, together with a reduction in
cognitive performance. Several gender differences were observed,
with males exhibiting greater sensitivity to aspartame exposure.
Our data supports previous observations that chronic exposure to
aspartame may result in memory deficits in rodents.
Supporting Information
Table S1. Correlations between body characteristics
and spatial memory variables in the MWM test.
(PDF)
Acknowledgments
We thank Jonathan Caigas, Rhea Mondreal, Rosario Ubungen, Razan
Bakheet and Qammar Al-Haffar for excellent technical assistance; and our
gratitude goes to Mr Hakim Al-Enazi for his unparalleled help in
coordinating research resources.
Author Contributions
Conceived and designed the experiments: KSC NJM FAA. Performed the
experiments: NJM MZZ SMS BA AI RAR. Analyzed the data: KSC NJM
MZZ. Wrote the paper: KSC.
References
1. Christian B, McConnaughey K, Bethea E, Brantley S, Coffey A, et al. (2004)
Chronic aspartame affects T-maze performance, brain cholinergic receptors and
Na+,K+-ATPase in rats. Pharmacol Biochem Behav 78(1): 121–127.
2. Humphries P, Pretorius E, Naude H (2008) Direct and indirect cellular effects of
aspartame on the brain. Eur J Clin Nutrition 62: 451–462.
3. Blanco M, Casado R, Va ´zquez F, Pumar JM (2006) CT and MR imaging
findings in methanol intoxication. AJNR Am J Neuroradiol 27(2): 452–454.
4. Inouye M, Murakami U (1973) Brain lesions in mouse infants and fetuses
induced by monosodium L. aspartate. Congen Anomal 13: 235–244.
5. Arai T, Hasegawa Y, Oki Y (1992) Changes in hepatic lipogenic enzyme
activities in voles and mice treated with monosodium aspartate. Res Vet Sci
53(2): 247–249.
6. Park CH, Choi SH, Piao Y, Kim S, Lee YJ, et al. (2000) Glutamate and
aspartate impair memory retention and damage hypothalamic neurons in adult
mice. Toxicol Lett 115(2): 117–125.
7. Blau N, van Spronsen FJ, Levy HL (2010) Phenylketonuria. Lancet 76;9750):
1417–1427.
8. Scriver CR, Byck S, Prevost L, Hoang L (1996) The phenylalanine hydroxylase
locus: a marker for the history of phenylketonuria and human genetic diversity.
PAH Mutation Analysis Consortium, Ciba Found Symp 197: 73–90.
9. Griffin RF, Humienny ME, Hall EC, Elsas LJ (1973) Classic phenylketonuria:
heterozygote detection during pregnancy. Am J Hum Genet 25(6): 646–654.
10. Jagenburg R, Rega ˚rdh CG, Ro ¨djer S (1977) Detection of heterozygotes for
phenylketonuria. Total body phenylalanine clearance and concentrations of
phenylalanine and tyrosine in the plasms of fasting subjects compared. Clin
Chem 23(9): 1654–1660.
11. Stegink LD, Filer LJ Jr., Bell EF, Ziegler EE, Tephly TR, et al. (1990) Repeated
ingestion of aspartame-sweetened beverages: further observations in individuals
heterozygous for phenylketonuria. Metabolism 39(10): 1076–1081.
12. Glushakov AV, Glushakova O, Varshney M, Bajpai LK, Sumners C, et al.
(2005) Long-term changes in glutamatergic synaptic transmission in phenylke-
tonuria. Brain 128(Pt 2): 300–307.
13. Liang L, Gu X, Lu L, Li D, Zhang X (2011) Phenylketonuria-related synaptic
changes in a BTBR-Pah(enu2) mouse model. Neuroreport 22(12): 617–622.
14. Cabib S, Pascucci T, Ventura R, Romano V, Puglisi-Allegra S (2003) The
behavioral profile of severe mental retardation in a genetic mouse model of
phenylketonuria. Behav Genet 33(3): 301–310.
15. Glushakov AV, Dennis DM, Morey TE, Sumners C, Cucchiara RF, et al. (2002)
Specific inhibition of N-methyl-D-aspartate receptor function in rat hippocam-
pal neurons by Phenylalaninenylalanine at concentrations observed during
phenylketonuria. Mol Psychiatry 7(4): 359–367.
16. Glushakov AV, Dennis DM, Sumners C, Seubert CN, Martynyuk AE (2003)
Phenylalaninenylalanine selectively depresses currents at glutamatergic excit-
atory synapses. J Neurosci Res 72(1): 116–124.
17. Martynyuk AE, Glushakov AV, Sumners C, Laipis PJ, Dennis DM, et al. (2005)
Impaired glutamatergic synaptic transmission in the PKU brain. Mol Genet
Metab 86 Suppl 1: S34–42.
18. Riedel G, Platt B, Micheau J (2003) Glutamate receptor function in learning and
memory. Behavioural Brain Res 140: 1–47.
19. Morris RG (1989) Synaptic plasticity and learning: selective impairment of
learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-
aspartate receptor antagonist AP5. J Neurosci 9(9): 3040–3057.
20. Yeh GC, Bonhaus DW, McNamara JO (1990) Evidence that zinc inhibits N-
methyl-D-aspartate receptor-gated ion channel activation by noncompetitive
antagonism of glycine binding. Mol Pharmacol 38(1): 14–19.
21. MacDonald JF, Bartlett MC, Mody I, Reynolds JN, Salter MW (1990) The PCP
site of the NMDA receptor complex. Adv Exp Med Biol 268: 27–34.
22. Izquierdo I (1994) Pharmacological evidence for a role of long-term potentiation
in memory. FASEB J 8: 1139–1145.
23. Stegink LD, Pitkin RM, Reynolds WA, Brummel MC, Filer LJ Jr. (1979)
Placental transfer of aspartate and its metabolites in the primate. Metabolism
28(6): 669–676.
24. Pueschel SM, Boylan JM, Jackson BT, Piasecki GJ (1982) A study of placental
transfer mechanisms in nonhuman primates using [14C]phenylalanine. Obstet
Gynecol 59(2): 182–188.
25. Stegink LD, Filer LJ Jr., BakerGL, McDonnell JE (1981) Letters to the Editor:
Aspartame doses for Phenylketonuria. J Nutr 111(9): 1688–1690.
26. Dow-Edwards DL, Scribani LA, Riley EP (1989) Impaired performance on
odor-aversion testing following prenatal aspartame exposure in the guinea pig.
Neurotoxicol Teratol 11(4): 413–416.
27. Brunner RL, Vorhees CV, Kinney L, Butcher RE (1979) Aspartame: assessment
of developmental psychotoxicity of a new artificial sweetener. Neurobehav
Toxicol 1(1): 79–86.
28. Kim JY, Seo J, Cho KH (2011) Aspartame-fed zebrafish exhibit acute deaths
with swimming defects and saccharin-fed zebrafish have elevation of cholesteryl
ester transfer protein activity in hypercholesterolemia, Food Chem Toxicol.
49(11): 2899–905.
29. Stokes AF, Belger A, Banich MT, Taylor H (1991) Effects of acute aspartame
and acute alcohol ingestion upon the cognitive performance of pilots. Aviat
Space Environ Med 62(7): 648–653.
30. Tilson HA, Hong JS, Sobotka TJ (1991) High doses of aspartame have no effects
on sensorimotor function or learning and memory in rats. Neurotoxicol Teratol
13(1): 27–35.
31. Gibbs ME, Richdale AL, Ng KT (1987) Effect of excess intracranial amino acids
on memory: a behavioural survey. Neurosci Biobehav Rev 11(3): 331–339.
32. Remke H, Wilsdorf A, Mu ¨ller F (1988) Development of hypothalamic obesity in
growing rats. Exp Pathol 33(4): 223–232.
33. Hermanussen M, Garcı ´a AP, Sunder M, Voight M, Salazar V, et al. (2006)
Obesity, voracity, and short stature: the impact of glutamate on the regulation of
appetite. Eur J Clin Nutr 60(1): 25–31.
34. Matyskova ´ R, Maletı ´nska ´ L, Maixnerova ´ J, Pirnı ´k Z, Kiss A, et al. (2008)
Comparison of the obesity phenotypes related to monosodium glutamate effect
on arcuate nucleus and/or the high fat diet feeding in C57BL/6 and NMRI
mice. Physiol Res 57(5): 727–734.
35. Nemeroff CB, Lipton MA, Kizer JS (1978) Models of neuroendocrine
regulation: use of monosodium glutamate as an investigational tool. Dev
Neurosci 1(2): 102–109.
36. Olney JW, Ho OL (1970) Brain damage in infant mice following oral intake of
glutamate, aspartate or cysteine. Nature 227: 609–610.
37. Peruzzo B, Pastor FE, Bla ´zquez JL, Scho ¨bitz K, Pelaez B, et al. (2000) A second
look at the barriers of the medial basal hypothalamus. Exp Brain Res 132(1):
10–26.
38. Yu T, Zhao Y, Shi W, Ma R, Yu L (1997) Effects of maternal oral
administration of monosodium glutamate at a late stage of pregnancy on
developing mouse fetal brain. Brain Res. 747(2): 195–206.
Aspartame-Induced Impairment of Spatial Cognition
PLoS ONE | www.plosone.org 12 April 2012 | Volume 7 | Issue 4 | e3157039. Joint Food and Agriculture Organization/World Health Organization (FAO/
WHO) Expert Committee on Food Additives (JECFA) (1988) : L-glutamic acid
and its ammonium, calcium, monosodium and potassium salts. WHO Food
Additives series 22: 97–161 New York Cambridge University Press.
40. Collison KS, Makhoul NJ, Inglis A, Al-Johi M, Zaidi MZ, et al. (2010) Dietary
trans-fat combined with monosodium glutamate induces dyslipidemia and
impairs spatial memory. Physiol Behav 99(3): 334–342.
41. Dubovicky ´ M, Skulte ´tyova ´ I, Jezova ´ D (1999) Neonatal stress alters habituation
of exploratory behavior in adult male but not female rats. Pharmacol Biochem
Behav 64(4): 681–686.
42. Maiter D, Underwood LE, Martin JB, Koenig JI (1991) Neonatal treatment with
monosodium glutamate: effects of prolonged growth hormone (GH)-releasing
hormone deficiency on pulsatile GH secretion and growth in female rats.
Endocrinology 128(2): 1100–1106.
43. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC
(1985) Homeostasis model assessment: insulin resistance and ß-cell function from
fasting plasma glucose and insulin concentrations in man. Diabetologia 28:
412–419.
44. Morris RJ (1984) Developments of a water-maze procedure for studying spatial
learning in the rat. J Neurosci Methods 11: 47–60.
45. Brody DL, Holtzman DM (2006) Morris water maze search strategy analysis in
PDAPP mice before and after experimental traumatic brain injury. Exp Neurol
197(2): 330–340.
46. Andreazzi AE, Scomparin DX, Mesquita FP, Balbo SL, Gravena C, et al. (2009)
Swimming exercise at weaning improves glycemic control and inhibits the onset
of monosodium L-glutamate-obesity in mice. J Endocrinol 201(3): 351–9.
47. Potts WJ, Bloss JL, Nutting EF (1980) Biological properties of aspartame. I.
Evaluation of central nervous system effects. Environ Pathol Toxicol 3(5–6):
341–345.
48. Reynolds WA, Butler V, Lemkey-Johnston N (1976) Hypothalamic morphology
following ingestion of aspartame or MSG in the neonatal rodent and primate: a
preliminary report. Toxicol Environ Health 2(2): 471–80.
49. Yokogoshi H, Roberts CH, Caballero B, Wurtman RJ (1984) Effects of
aspartame and glucose administration on brain and plasma levels of large
neutral amino acids and brain 5-hydroxyindoles. Am J Clin Nutr 40(1): 1–7.
50. Levy HL (1999) Phenylketonuria: old disease, new approach to treatment
[editorial]. Proc Natl Acad Sci USA 96, 1811–1813.
51. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC (1995) The hyperphenyl-
alaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The
metabolic and molecular bases of inherited disease, New York: McGraw-Hill
1(7), 1015–1075.
52. Tourian A, Treiman DM, Carr JS (1972) Developmental biology of hepatic
phenylalanine hydroxylase activity in foetal and neonatal rats synchronized as to
conception. Biochem Biophys Acta. 279(3), 484–490.
53. Dhondt JL, Dautrevaux M, Biserte G, Farriaux JP (1979) Developmental aspect
of phenylalanine hydroxylase in the rat – hormonal influences. Mech Ageing
Dev 10(3–4), 219–224.
54. Faust DM, Catherin A-M, Barbaux S, Belkadi L, Imaizumi-Scherrer T, et al.
(1996) The Activity of the Highly Inducible Mouse Phenylalanine Hydroxylase
Gene Promoter Is Dependent upon a Tissue-Specific, Hormone-Inducible
Enhancer. Mol Cell Biol 16 (6); 3125–3137.
55. Cabib S, Pascucci T, Ventura R, Romano V, Puglisi-Allegra S (2003) The
behavioral profile of severe mental retardation in a genetic mouse model of
phenylketonuria. Behav Genet. 33(3): 301–10.
56. Zagreda L, Goodman J, Druin DP, McDonald D, Diamond A (1999) Cognitive
deficits in a genetic mouse model of the most common biochemical cause of
human mental retardation. J Neurosci. 19(14): 6175–82.
57. Gassio ´ R, Artuch R, Vilaseca MA, Fuste ´ E, Boix C, et al. (2005) Cognitive
functions in classic phenylketonuria and mild hyperphenylalaninaemia:
experience in a paediatric population. Dev Med Child Neurol. 47(7): 443–8.
58. Janzen D, Nguyen M (2010) Beyond executive function: non-executive cognitive
abilities in individuals with PKU. Mol Genet Metab. 99 Suppl 1: S47–51.
59. Ercal N, Aykin-Burns N, Gurer-Orhan H, McDonald JD (2002) Oxidative stress
in a phenylketonuria animal model. Free Radic Biol Med 32: 906–911.
60. Mazzola PN, Terra M, Rosa AP, Mescka CP, Moraes TB, et al. (2011) Regular
exercise prevents oxidative stress in the brain of hyperphenylalaninemic rats.
Metab Brain Dis 26(4): 291–7.
61. Whalley LJ, Deary IJ, Appleton CL, Starr JM (2004) Cognitive reserve and the
neurobiology of cognitive aging. Ageing Res Rev. 3(4): 369–82.
62. Abdel-Salam OM, Salem NA, Hussein JS (2011) Effect of Aspartame on
Oxidative Stress and Monoamine Neurotransmitter Levels in Lipopolysaccha-
ride-Treated Mice. Neurotox Res. Aug 6. [Epub ahead of print].
63. Wolff M, Savova M, Malleret G, Segu L, Buhot MC (2002) Differential learning
abilities of 129T2/Sv and C57BL/6J mice as assessed in three water maze
protocols. Behav Brain Res 136(2): 463–474.
64. Wolfer DP, Stagljar-Bozicevic M, Errington ML, Lipp HP (1998) Spatial
memory and learning in transgenic mice: fact or artifact? News Physiol Sci 13:
118–123.
65. Devan BD, White NM (1999) Parallel information processing in the dorsal
striatum: relation to hippocampal function. J Neurosci 19(7): 2789–2798.
66. Hostetter G, Thomas GJ (1967) Evaluation of enhanced thigmotaxis as a
condition of impaired maze learning by rats with hippocampal lesions. J Comp
Physiol Psychol 63(1): 105–110.
67. Cain DP, Saucier D, Hall J, Hargreaves EL, Boon F (1996) Detailed behavioral
analysis of water maze acquisition under APV or CNQX: contribution of
sensorimotor disturbances to drug-induced acquisition deficits. Behav Neurosci
110(1): 86–102.
68. Saucier D, Hargreaves EL, Boon F, Vanderwolf CH, Cain DP (1996) Detailed
behavioral analysis of water maze acquisition under systemic NMDA or
muscarinic antagonism: nonspatial pretraining eliminates spatial learning
deficits. Behav Neurosci 110(1): 103–116.
69. Mahalik MP, Gautieri RF (1984) Reflex responsiveness of CF-1 mouse neonates
following maternal aspartame exposure. Res Commun Psychol Psychiatry Behav
9: 385–403.
70. McAnulty PA, Collier MJ, Enticott J, Tesh JM, Mayhew DA, et al. (1989)
Absence of developmental effects in CF-1 mice exposed to aspartame in utero.
Fundam Appl Toxicol 13(2): 296–302.
71. Cox DJ, Kovatchev BP, Gonder-Frederick LA, Summers KH, McCall A, et al.
(2005) Relationship between hyperglycemia and cognitive performance among
adults with type 1 and type 2 diabetes. Diabetes Care 28 (1), 71–77.
72. Ishii H, Koshimizu T, Usami S, Fujimoto T (1981) Toxicity of aspartame and its
diketopiperazine for Wistar rats by dietary administration for 104 weeks,
Toxicology 21(2): 91–94.
73. Yang Q (2010) Gain weight by ‘‘going diet? ’’ Artificial sweeteners and the
neurobiology of sugar cravings: Neuroscience, Yale J Biol Med 83(2): 101–108.
74. Fowler SP, Williams K, Resendez RG, Hunt KJ, Hazuda HP, et al. (2008)
Fueling the obesity epidemic? Artificially sweetened beverage use and long-term
weight gain. Obesity (Silver Spring Md.) 16: 1894–1900.
75. Ferland A, Brassard P, Poirier P (2007) Is aspartame really safer in reducing the
risk of hypoglycemia during exercise in patients with type 2 diabetes?. Diabetes
Care 30(7): e59.
76. Hlina ´k Z, Gandalovicova ´ D, Krejcı ´ I (2005) Behavioral deficits in adult rats
treated neonatally with glutamate. Neurotoxicol Teratol 27(3): 465–473.
77. Nascimento Curi CM, Marmo MR, Egami M, Ribeiro EB, Andrade IS, et al.
(1991) Effect of monosodium glutamate treatment during neonatal development
on lipogenesis rate and lipoprotein lipase activity in adult rats. Biochem Int.
24(5): 927–35.
78. Yaffe K (2007) Metabolic syndrome and cognitive decline. Curr Alzheimer Res;
4(2): 123–6.
79. Janus C (2004) Search strategies used by APP transgenic mice during navigation
in the Morris water maze. Learn Mem; 11(3): 337–46.
80. Jurdak N, Lichtenstein AH, Kanarek RB (2008) Diet-induced obesity and spatial
cognition in young male rats. Nutr Neurosci. 11(2): 48–54.
81. Benice TS, Rizk A, Kohama S, Pfankuch T, Raber J (2006) Sex-differences in
age-related cognitive decline in C57BL/6J mice associated with increased brain
microtubule-associated protein 2 and synaptophysin immunoreactivity. Neuro-
science 137(2): 413–23.
Aspartame-Induced Impairment of Spatial Cognition
PLoS ONE | www.plosone.org 13 April 2012 | Volume 7 | Issue 4 | e31570